McGowan v. Medpace, Inc.

2015 Ohio 3743
CourtOhio Court of Appeals
DecidedSeptember 16, 2015
DocketC-140634, C-140652
StatusPublished
Cited by5 cases

This text of 2015 Ohio 3743 (McGowan v. Medpace, Inc.) is published on Counsel Stack Legal Research, covering Ohio Court of Appeals primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
McGowan v. Medpace, Inc., 2015 Ohio 3743 (Ohio Ct. App. 2015).

Opinion

[Cite as McGowan v. Medpace, Inc., 2015-Ohio-3743.]

IN THE COURT OF APPEALS FIRST APPELLATE DISTRICT OF OHIO HAMILTON COUNTY, OHIO

MARY MCGOWAN, M.D., : APPEAL NOS. C-140634 C-140652 Plaintiff-Appellee/Cross- : TRIAL NO. A-1108336 Appellant, : O P I N I O N. vs. : MEDPACE, INC., : Defendant-Appellant/Cross- Appellee. :

Civil Appeals From: Hamilton County Court of Common Pleas

Judgment Appealed From Is: Reversed and Cause Remanded

Date of Judgment Entry on Appeal: September 16, 2015

Freking & Betz, LLC, Randolph Freking and Brian P. Gillan, for Plaintiff- Appellee/Cross-Appellant Mary McGowan, M.D.,

Thompson Hine LLP, Deborah S. Brenneman and George B. Musekamp, for Defendant-Appellant/Cross-Appellee Medpace, Inc.,

The Gittes Law Group, Frederick M. Gittes and Jeffrey P. Vardaro, for Amicus Curiae the Ohio Employment Lawyers Association.

Please note: this case has been removed from the accelerated calendar. OHIO FIRST DISTRICT COURT OF APPEALS

FISCHER, Judge.

{¶1} Defendant-appellant/cross-appellee Medpace, Inc., and plaintiff-

appellee/cross-appellant Mary McGowan, M.D., have appealed from the trial court’s

order entering final judgment in favor of McGowan on her claim against Medpace for

wrongful discharge in violation of public policy. Because McGowan failed to identify

a clear public policy in support of her wrongful-discharge claim, we hold that the trial

court erred by failing to grant a directed verdict to Medpace.

Background and Procedure

{¶2} Medpace is a research facility that designs and conducts clinical trials

to test new pharmaceuticals. In the spring of 2011, Medpace hired McGowan as an

at-will employee to take over duties from one of its retiring physicians, Dr. Evan

Stein. McGowan was hired as the executive director of both Medpace’s Clinical

Pharmacology Unit (“CPU”) and its Metabolic and Atherosclerosis Research Center

(“MARC”). The CPU conducted phase one studies to observe participants’ first

exposure to a drug. The MARC conducted later-stage studies on various drugs. The

sponsor of each drug study in the MARC selected a principal investigator to run the

study. McGowan was responsible for recruiting new studies to the MARC, and she

was additionally appointed by Stein to replace him as the principal investigator on

studies that he had previously recruited. McGowan had additionally agreed to take

over control of Stein’s private practice, the Cholesterol Treatment Center (“CTC”).

The CTC was not affiliated with Medpace and was solely owned by Stein, although it

was located on Medpace’s premises. Most participants in the MARC studies were

patients at the CTC, and the two entities shared employees.

2 OHIO FIRST DISTRICT COURT OF APPEALS

{¶3} Shortly after taking over the CTC, McGowan observed several practices

in the facility that troubled her. Stein had prescribed patients a larger dose of

medication than was medically necessary, and had then directed the patients to split

the prescribed pills. McGowan felt that this practice of pill splitting constituted

insurance fraud and compromised patient safety because the written prescription

provided to the pharmacy did not match the instructions in a patient’s chart.

McGowan was further troubled by Stein’s practice of combining into one chart the

medical records of CTC patients who were enrolled in a MARC study. In her opinion,

personal information necessary to the CTC chart was irrelevant to treatment in the

MARC and should not be contained in the MARC files. Last, McGowan was

concerned with the MARC’s practice of leaving patient charts open on carts outside

of treatment rooms. She felt that these two practices were in violation of the Health

Insurance Portability and Accountability Act (“HIPAA”).

{¶4} McGowan contacted a health-care attorney regarding her concerns

about Stein’s pill-splitting and prescription-writing practices. After receiving

confirmation from this attorney that her concerns were legitimate, McGowan called a

staff meeting on July 22, 2011. At this meeting, she instructed the staff that they had

to change the way that prescriptions were written and the way that charts were

handled. McGowan stated that Stein’s prescription-writing practices had been

fraudulent. After learning of this meeting and McGowan’s accusations, Stein

removed McGowan from all activity in both the MARC and CTC via an email sent on

July 25, 2011.

{¶5} On July 27, 2011, McGowan met with August Troendle, Medpace’s

president and CEO, and Tiffany Khodadad, Medpace’s executive director of human

3 OHIO FIRST DISTRICT COURT OF APPEALS

resources. During this meeting, McGowan raised her concerns about Stein’s

prescription-writing practices and the HIPAA violations that she felt she had

observed. Troendle told McGowan that it was inappropriate for her to have accused

Stein of fraud in front of the staff. He stated that her concerns would be investigated,

and he encouraged her to investigate them as well. According to Troendle, McGowan

was adamant that Stein had committed fraud and that she had the right to air her

concerns to whomever she wished. Troendle clarified to McGowan that she was still

the executive director of the MARC, but that he could not control whether Stein

retained control of the CTC or the studies at MARC that he had previously recruited.

Neither McGowan’s title nor salary changed after Stein took back control of the CTC

and his MARC studies.

{¶6} On July 28, 2011, McGowan sent an email to Khodadad, Troendle, and

Kay Nolan, Medpace’s general counsel. In the email, McGowan stated that she felt

she was being retaliated against for expressing her concerns about improper

practices at the CTC. She stated that Troendle had informed her that she would not

be restored to director of either the CTC or MARC until she apologized to Stein, and

that Troendle had referred to Stein as an “asshole” and an “egomaniac.” Troendle

responded to this email, denying that he had referred to Stein in such a manner and

clarifying that McGowan remained head of the CPU, but that he had no authority to

remove Stein as the principal investigator on Steins’ MARC studies.

{¶7} Following this meeting and email exchange, McGowan continued her

duties as director of the CPU. But she felt that she could be fired from Medpace at

any point, and she retained an attorney. On August 17, 2011, McGowan attended a

standard Medpace staff meeting. At Troendle’s request, she stayed after the meeting

4 OHIO FIRST DISTRICT COURT OF APPEALS

to speak with him. Troendle acknowledged that McGowan had hired an attorney to

negotiate her departure from Medpace, but expressed his desire for her to continue

her employment. McGowan told Troendle that she was disappointed that he had lied

about calling Stein an asshole. Troendle again told McGowan that it had been

inappropriate to accuse Stein of fraud in front of the staff. McGowan stated that

Troendle could not stop her from speaking the truth and she accused Troendle of

trying to intimidate her.

{¶8} After that meeting, Troendle determined that he had to terminate

McGowan’s employment with Medpace. On August 18, 2011, two representatives

from Medpace’s department of human resources informed McGowan that she had

been fired.

{¶9} On October 19, 2011, McGowan sued Medpace for wrongful discharge

Free access — add to your briefcase to read the full text and ask questions with AI

Related

McGowan v. Medpace, Inc.
2017 Ohio 4396 (Ohio Supreme Court, 2017)
McGowan v. Medpace, Inc. (Slip Opinion)
2017 Ohio 1340 (Ohio Supreme Court, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
2015 Ohio 3743, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mcgowan-v-medpace-inc-ohioctapp-2015.